Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Pharma
J&J innovative medicine chief Jennifer Taubert to retire
J&J has named Tom Cavanaugh as the new leader of its innovative medicines business, beginning Sept. 1, 2026.
Angus Liu
Aug 4, 2026 10:55am
With $5.5B sales, AbbVie's Skyrizi matches Humira's best quarter
Jul 31, 2026 11:18am
J&J proposes $5.5B deal to resolve 76,000 ovarian cancer claims
Jul 28, 2026 11:26am
Legend Biotech CEO resigns; search underway for replacement
Jul 27, 2026 9:32am
Generic tariffs, Samsung Bio, HK IPO—Fierce Pharma Asia
Jul 24, 2026 9:00am
J&J bispecific combo delivers 89% PFS benefit in myeloma
Jul 23, 2026 8:30am
